Glaucoma is a prevalent group of diseases whose common feature is progressive death of retinal ganglion cells (RGCs), optic nerve degeneration, and eventually blindness.
1,2 The most common form of glaucoma, primary open-angle glaucoma (POAG), is often associated with elevated IOP. However, glaucomatous degeneration of the optic nerve also may develop in individuals without elevated IOP.
3 Despite decades of research, the causative mechanisms of glaucomatous neurodegeneration are still largely unclear.
4–6 Different genes have been identified that account for a small proportion of POAG. In most cases, POAG is inherited as a complex trait.
7,8 The first identified and the most studied gene is
MYOC, which is highly expressed in the human trabecular meshwork (TM)
9 but also expressed in other ocular tissues, such iris, ciliary body, and optic nerve.
10,11 Several studies have suggested that
MYOC mutations are associated with 3% to 4% of POAG patient populations worldwide.
12 The role of myocilin in POAG is not fully understood.
11,12 Intracellular accumulation of myocilin aggregates is believed to deteriorate TM function and cause IOP elevation.
13–15 Specific
MYOC mutations seem to be associated with different levels of IOP elevation and severity of optic neuropathy.
16 However, mice with either deletion of the
Myoc gene
17 or overexpression of wild-type (wt)
Myoc 18 have normal IOP and no RGC/axon degeneration, suggesting a gain-of-function property of mutated
MYOC.
18 Transgenic (Tg) mice expressing the Tyr423His mutant of mouse
19 or Tyr437His human
20 myocilin proteins develop modest IOP elevation and mild RGC loss in the peripheral retina of aged mice. Transgenic mice expressing high levels of mutated human myocilin (Tyr437His) under the control of the cytomegalovirus promoter develop elevated IOP, and early, progressive RGC death and axonal degeneration.
15